Neurodegeneration – News and Features

Study finds human stem cells derived from bone marrow are predisposed to develop into a variety of nerve cell types.

Cells may be useful in therapies for ALS, Parkinson's, Multiple Sclerosis and other neurodegenerative diseases.

The event will feature five major sections this year, including New Targets, Drug Discovery Approaches, Channelopathies, CNS & Neurodegeneration and Technologies.

Carnegie Mellon University and the University of Pittsburgh receive the grant to establish a National Technology Center for Networks and Pathways.

Posiphen may support stem cell transplantation in Alzheimer's disease.

The placental-derived stem cells build on Celgene Cellular Therapeutics deep experience and patented procedures.

The findings of this analysis are of particular interest for molecular biology, nanotechnology and environmental analyses.

The Australian Stem Cell Centre, Monash University and the University of California make a major commitment towards stem cell research

AppTec to manufacture multiple sclerosis drug candidate for toxicology studies and clinical trial using ACE System.

Patent Covers Any Chemically Modified siRNA Sequence Used Against the Targeted Gene and Sets Precedent for Sirna Therapeutics' Substantial Target Patent Portfolio in the U.S.